Local administration of delta9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid action
- PMID: 10353438
- PMCID: PMC2862358
- DOI: 10.1007/s002130050955
Local administration of delta9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid action
Abstract
Rationale: Cannabinoids can reduce nociceptive responses by acting on peripheral cannabinoid receptors in rodents.
Objectives: The study was conducted to evaluate the hypothesis that local administration of delta9-tetrahydrocannabinol (delta9-THC) can attenuate capsaicin-induced nociception in rhesus monkeys.
Methods: Capsaicin (100 microg) was applied locally in the tail of rhesus monkeys to evoke a nociceptive response, thermal allodynia, in normally innocuous 46 degrees C water. delta9-THC (10-320 microg) was coadministered with capsaicin in the tail to assess local antinociceptive effects. In addition, a local antagonism study was performed to confirm the selectivity of delta9-THC action.
Results: delta9-THC dose-dependently inhibited capsaicin-induced allodynia. This local antinociception was antagonized by small doses (10-100 microg) of the cannabinoid CB1 antagonist, SR141716A, applied in the tail. However, 100 microg SR141716A injected subcutaneously in the back did not antagonize local delta9-THC.
Conclusions: These results indicate that the site of action of locally applied delta9-THC is in the tail. It provides functional evidence that activation of peripheral cannabinoid CB1 receptors can attenuate capsaicin-induced thermal nociception in non-human primates and suggests a new approach for cannabinoids in pain management.
Figures


Similar articles
-
Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.Psychopharmacology (Berl). 2006 Oct;188(3):306-14. doi: 10.1007/s00213-006-0500-6. Epub 2006 Sep 5. Psychopharmacology (Berl). 2006. PMID: 16953389
-
Two distinctive antinociceptive systems in rats with pathological pain.Neurosci Lett. 2000 Feb 11;280(1):13-6. doi: 10.1016/s0304-3940(99)00998-2. Neurosci Lett. 2000. PMID: 10696800
-
Orphanin FQ inhibits capsaicin-induced thermal nociception in monkeys by activation of peripheral ORL1 receptors.Br J Pharmacol. 2002 Feb;135(4):943-50. doi: 10.1038/sj.bjp.0704535. Br J Pharmacol. 2002. PMID: 11861322 Free PMC article.
-
Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A.J Pharmacol Exp Ther. 1998 Aug;286(2):697-703. J Pharmacol Exp Ther. 1998. PMID: 9694923
-
Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.J Pharmacol Exp Ther. 2012 Mar;340(3):787-800. doi: 10.1124/jpet.111.188540. Epub 2011 Dec 19. J Pharmacol Exp Ther. 2012. PMID: 22182934
Cited by
-
Interactions between μ-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration.J Pharmacol Exp Ther. 2013 Jun;345(3):354-62. doi: 10.1124/jpet.113.204099. Epub 2013 Mar 27. J Pharmacol Exp Ther. 2013. PMID: 23536317 Free PMC article.
-
Translational value of non-human primates in opioid research.Exp Neurol. 2021 Apr;338:113602. doi: 10.1016/j.expneurol.2021.113602. Epub 2021 Jan 14. Exp Neurol. 2021. PMID: 33453211 Free PMC article. Review.
-
Distinct BOLD fMRI Responses of Capsaicin-Induced Thermal Sensation Reveal Pain-Related Brain Activation in Nonhuman Primates.PLoS One. 2016 Jun 16;11(6):e0156805. doi: 10.1371/journal.pone.0156805. eCollection 2016. PLoS One. 2016. PMID: 27309348 Free PMC article.
-
Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.Eur J Pharmacol. 2007 Mar 8;558(1-3):73-87. doi: 10.1016/j.ejphar.2006.11.062. Epub 2006 Dec 9. Eur J Pharmacol. 2007. PMID: 17250825 Free PMC article.
-
Comparative antinociceptive effect of arachidonylcyclopropylamide, a cannabinoid 1 receptor agonist & lignocaine, a local anaesthetic agent, following direct intrawound administration in rats.Indian J Med Res. 2016 Nov;144(5):730-740. doi: 10.4103/ijmr.IJMR_1402_15. Indian J Med Res. 2016. PMID: 28361827 Free PMC article.
References
-
- Calignano A, La Rana G, Giuffrida A, Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature. 1998;394:277–281. - PubMed
-
- Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997;389:816–824. - PubMed
-
- Compton DR, Aceto MD, Lowe J, Martin BR. In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J Pharmacol Exp Ther. 1996;277:586–594. - PubMed
-
- Dray A. Peripheral mediators of pain. In: Dickenson A, Besson J-M, editors. The pharmacology of pain. Berlin: Springer; 1997. pp. 21–41.
-
- Felder CC, Glass M. Cannabinoid receptors and their endogenous agonists. Annu Rev Pharmacol Toxicol. 1998;38:179–200. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical